J. Roth

发表

Tandem Mass Spectral Libraries of Peptides in Digests of Individual Proteins: Human Serum Albumin (HSA) *

Yuri A. Mirokhin, Lisa E. Kilpatrick, S. Stein, 2014, Molecular & Cellular Proteomics.

Assessing data quality of peptide mass spectra obtained by quadrupole ion trap mass spectrometry.

S. Bryant, L. Geer, S. Markey, 2005, Journal of proteome research.

A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.

Yuri A. Mirokhin, Ratna R. Thangudu, K. Ketchum, 2016, Journal of proteome research.

Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides.

J. Roth, V. Marquez, J. Driscoll, 1986, Journal of medicinal chemistry.

A pediatric phase I and pharmacokinetic study of spirohydantoin mustard.

F. Balis, G. Reaman, R. Packer, 1988, Cancer research.

Evaluation of a fluorogenic derivatization method for the reversed-phase HPLC analysis of 2'-beta-fluoro-2',3'-dideoxyadenosine, a new anti-AIDS drug.

J. Roth, J. Kelley, H. Ford, 2001, Journal of pharmaceutical and biomedical analysis.

Determination of 2′-β-fluoro-2′,3′-dideoxyadenosine, an experimental anti-AIDS drug, in human plasma by high-performance liquid chromatography

H. Mitsuya, J. Roth, J. Kelley, 1998 .

Determination of the Anti-HIV Drug 2′-β-Fluoro-2′, 3′-Dideoxyadenosine in Biological Fluids by Reversed-Phase HPLC

J. Roth, J. Kelley, 1995 .

Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.

H. Mitsuya, J. Roth, V. Marquez, 1995, Journal of medicinal chemistry.

Spiromustine analogues. Relationships between structure, plasma stability, and antitumor activity.

J. Roth, J. Driscoll, R. Heideman, 1986, Journal of Pharmacy and Science.

Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV.

H. Mitsuya, S. Broder, J. Roth, 1990, Journal of medicinal chemistry.

A Phase I unavailability and Pharmacokinetic Study of Hexamethylene Bisacetamide (NSC 95580) Administered via Nasogastric Tube1

B. Leyland-Jones, R. Weiss, J. Roth, 2006 .

Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.

B. Leyland-Jones, R. Weiss, J. Roth, 1991, Cancer research.

Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography.

J. Roth, J. Kelley, H. Chun, 1994, Journal of chromatography.

Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats

J. Roth, J. Kelley, C. Litterst, 2004, Investigational New Drugs.

Gas Chromatographic Determination of Hexamethylene Bisacetamide in Plasma and Urine

J. Roth, J. Kelley, C. Litterst, 1985 .

A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).

G. Curt, G. Batist, R. Fine, 1985, Cancer research.

Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.

H. Mitsuya, J. Roth, T. Shirasaka, 1992, Journal of medicinal chemistry.

The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.

D. Vistica, S. Broder, F. Balis, 1987, Drug metabolism and disposition: the biological fate of chemicals.

2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV).

H. Mitsuya, S. Broder, J. Roth, 1987, Biochemical pharmacology.

Chemistry and Anti‐HIV Properties of 2′‐Fluoro‐2′,3′‐ dideoxyarabinofuranosylpyrimidines.

H. Mitsuya, J. Roth, T. Shirasaka, 1992 .

Acid-Stable 2′-Fluoro Purine Dideoxynucleosides as Active Agents Against HIV.

H. Mitsuya, S. Broder, J. Roth, 1990 .

Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.

J. Roth, J. Wang, J. Kelley, 2000, Journal of mass spectrometry : JMS.

Reverse phase HPLC determination and murine pharmacokinetics of arabinosyl-5-azacytosine

J. Roth, R. Heideman, J. Kelley, 1989 .

Facile hydrolytic cleavage of N,O-diheptafluorobutyryl derivatives of thyroidal amino acids

R. Rapaka, J. Roth, V. K. Prasad, 1982 .

2 *-b-FLUORO-2 * , 3 *-DIDEOXYADENOSINE , LODENOSINE , IN RHESUS MONKEYS : PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS AND URINARY DISPOSITION 1

F. Balis, J. Roth, D. Poplack, 1999 .

2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.

F. Balis, J. Roth, D. Poplack, 1999, Drug metabolism and disposition: the biological fate of chemicals.

A simple HPLC method for the dissolution studies on levothyroxine sodium tablets

R. Rapaka, J. Roth, V. K. Prasad, 1982 .

Interconversion of Peptide Mass Spectral Libraries Derivatized with iTRAQ or TMT Labels.

Stephen E. Stein, Yuri A. Mirokhin, Dmitrii V. Tchekhovskoi, 2016, Journal of proteome research.

Improved method for the analysis of furosemide in plasma by high-performance liquid chromatography.

R. Rapaka, J. Roth, B. Cabana, 1982, Journal of chromatography.

The analysis of 4-chloro-5-sulfamoylanthranilic acid in the bulk material and pharmaceutical preparations of furosemide by a high-performance liquid chromatographic method

R. Rapaka, J. Roth, V. K. Prasad, 1982 .

An HPLC Procedure for the Analysis of Furosemide in Pharmaceuticals-Analysis of Furosemide Tablets and Furosemide Injection

R. Rapaka, J. Roth, V. K. Prasad, 1981 .

Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.

J. Roth, J. Tomaszewski, J. Driscoll, 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

SpectraST: An open-source MS/MS spectra-matching search tool for targeted proteomics

Henry H N Lam, Ruedi Aebersold, Jimmy K. Eng, 2006 .